# Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial

> **NCT05683444** · EARLY_PHASE1 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 16 (actual)

## Conditions studied

- Lymphatic Diseases
- Chylothorax

## Interventions

- **DRUG:** Octreotide infusion
- **DRUG:** Saline infusion

## Key facts

- **NCT ID:** NCT05683444
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-01
- **Primary completion:** 2021-03-26
- **Final completion:** 2021-03-26
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05683444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05683444, "Octreotide Improves Human Lymphatic Fluid Transport a Translational Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05683444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*